FI972629A0 - Aryyli- ja heteroaryylisulfonamidijohdoksia, niiden valmistus ja niiden käyttö endoteliinin antagonisteina - Google Patents
Aryyli- ja heteroaryylisulfonamidijohdoksia, niiden valmistus ja niiden käyttö endoteliinin antagonisteinaInfo
- Publication number
- FI972629A0 FI972629A0 FI972629A FI972629A FI972629A0 FI 972629 A0 FI972629 A0 FI 972629A0 FI 972629 A FI972629 A FI 972629A FI 972629 A FI972629 A FI 972629A FI 972629 A0 FI972629 A0 FI 972629A0
- Authority
- FI
- Finland
- Prior art keywords
- signifies
- alkyl
- phenyl
- heterocyclyl
- substituted phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH383894 | 1994-12-20 | ||
CH383894 | 1994-12-20 | ||
CH307995 | 1995-10-31 | ||
CH307995 | 1995-10-31 | ||
EP9504762 | 1995-12-04 | ||
PCT/EP1995/004762 WO1996019455A1 (en) | 1994-12-20 | 1995-12-04 | Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
Publications (3)
Publication Number | Publication Date |
---|---|
FI972629A0 true FI972629A0 (fi) | 1997-06-18 |
FI972629A FI972629A (fi) | 1997-06-18 |
FI116622B FI116622B (fi) | 2006-01-13 |
Family
ID=31189207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI972629A FI116622B (fi) | 1994-12-20 | 1997-06-18 | Aryyli- ja heteroaryylisulfonamidijohdoksia, niiden valmistus ja niiden käyttö endoteliinin antagonisteina |
Country Status (25)
Country | Link |
---|---|
US (2) | US5962682A (fi) |
EP (1) | EP0799206B1 (fi) |
JP (1) | JP2930731B2 (fi) |
KR (1) | KR100432843B1 (fi) |
CN (1) | CN1136192C (fi) |
AT (1) | ATE223899T1 (fi) |
AU (1) | AU695255B2 (fi) |
BR (1) | BR9510533A (fi) |
CA (1) | CA2208011A1 (fi) |
CZ (1) | CZ289090B6 (fi) |
DE (1) | DE69528198T2 (fi) |
DK (1) | DK0799206T3 (fi) |
ES (1) | ES2180664T3 (fi) |
FI (1) | FI116622B (fi) |
HU (1) | HUT77307A (fi) |
IL (1) | IL116410A (fi) |
MA (1) | MA23745A1 (fi) |
MX (1) | MX9704588A (fi) |
MY (1) | MY113214A (fi) |
NO (1) | NO308297B1 (fi) |
NZ (1) | NZ297774A (fi) |
PT (1) | PT799206E (fi) |
RU (1) | RU2163598C2 (fi) |
TW (1) | TW474920B (fi) |
WO (1) | WO1996019455A1 (fi) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
US6342610B2 (en) | 1993-05-20 | 2002-01-29 | Texas Biotechnology Corp. | N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US6376523B1 (en) | 1994-05-20 | 2002-04-23 | Texas Biotechnology Corporation | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
US6541498B2 (en) | 1993-05-20 | 2003-04-01 | Texas Biotechnology | Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
ATE223899T1 (de) * | 1994-12-20 | 2002-09-15 | Hoffmann La Roche | Aryl-und hetaryl-sulfonamid derivate, deren herstellung und deren verwendung als endothelin- antagonisten |
US5977117A (en) | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
US5804585A (en) | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
US6653331B2 (en) * | 1996-07-03 | 2003-11-25 | Pharmacia & Upjohn Company | Targeted drug delivery using sulfonamide derivatives |
TR200101905T2 (tr) | 1997-04-28 | 2002-06-21 | Texas Biotechnology Corporation | Endotelin ile ilgili hastalıkların tedavisinde kullanılan sülfanoamidler. |
US5783705A (en) | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
US6191170B1 (en) * | 1998-01-13 | 2001-02-20 | Tularik Inc. | Benzenesulfonamides and benzamides as therapeutic agents |
CA2315614C (en) | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
BR0016241A (pt) * | 1999-12-22 | 2002-11-12 | Actelion Pharmaceuticals Ltd | Compostos, composições farmacêuticas, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas |
DK1533311T3 (da) | 1999-12-31 | 2007-09-17 | Encysive Pharmaceuticals Inc | Sulfonamider og derivater deraf, der modulerer aktiviteten af endothelin |
US6387915B2 (en) | 2000-05-31 | 2002-05-14 | Pfizer Inc. | Isoxazole-sulfonamide endothelin antagonists |
US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
MXPA05006701A (es) * | 2002-12-20 | 2006-03-30 | Amgen Inc | Moduladores de asma y de inflacion alergica. |
WO2004073619A2 (en) * | 2003-02-14 | 2004-09-02 | Smithkline Beecham Corporation | Ccr8 antagonists |
WO2004074438A2 (en) * | 2003-02-14 | 2004-09-02 | Smithkline Beecham Corporation | Ccr8 antagonists |
EA201001029A1 (ru) * | 2007-12-19 | 2011-06-30 | Амген Инк. | Производные фенилуксусной кислоты в качестве модуляторов процесса воспаления |
WO2010015623A1 (en) * | 2008-08-05 | 2010-02-11 | Farmaprojects, S. A. | Process for the preparation of endothelin receptor antagonists |
AR076221A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
CN110092743B (zh) | 2018-01-30 | 2022-03-15 | 中国医学科学院药物研究所 | 苯甲酰胺类化合物及其制备方法、用途和药物组合物 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1521932A (en) * | 1976-03-08 | 1978-08-16 | Labaz | Sulphonamide derivatives and process for preparing the same |
GB8708233D0 (en) * | 1987-04-07 | 1987-05-13 | Smith Kline French Lab | Pharmaceutically active compounds |
DE69129611T2 (de) * | 1990-08-20 | 1998-12-17 | Eisai Co., Ltd., Tokio/Tokyo | Sulfonamid-Derivate |
TW270116B (fi) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
NZ247440A (en) * | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
TW287160B (fi) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche | |
IL111959A (en) * | 1993-12-17 | 2000-07-16 | Tanabe Seiyaku Co | N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them |
GB9504854D0 (en) * | 1994-03-31 | 1995-04-26 | Zeneca Ltd | Nitrogen derivatives |
ATE223899T1 (de) * | 1994-12-20 | 2002-09-15 | Hoffmann La Roche | Aryl-und hetaryl-sulfonamid derivate, deren herstellung und deren verwendung als endothelin- antagonisten |
-
1995
- 1995-12-04 AT AT95941660T patent/ATE223899T1/de not_active IP Right Cessation
- 1995-12-04 KR KR1019970704136A patent/KR100432843B1/ko not_active IP Right Cessation
- 1995-12-04 PT PT95941660T patent/PT799206E/pt unknown
- 1995-12-04 NZ NZ297774A patent/NZ297774A/xx unknown
- 1995-12-04 CZ CZ19971873A patent/CZ289090B6/cs not_active IP Right Cessation
- 1995-12-04 CA CA002208011A patent/CA2208011A1/en not_active Abandoned
- 1995-12-04 CN CNB951969595A patent/CN1136192C/zh not_active Expired - Fee Related
- 1995-12-04 HU HU9701811A patent/HUT77307A/hu unknown
- 1995-12-04 AU AU43016/96A patent/AU695255B2/en not_active Ceased
- 1995-12-04 DK DK95941660T patent/DK0799206T3/da active
- 1995-12-04 DE DE69528198T patent/DE69528198T2/de not_active Expired - Fee Related
- 1995-12-04 JP JP8519459A patent/JP2930731B2/ja not_active Expired - Fee Related
- 1995-12-04 US US08/860,985 patent/US5962682A/en not_active Expired - Fee Related
- 1995-12-04 WO PCT/EP1995/004762 patent/WO1996019455A1/en active IP Right Grant
- 1995-12-04 ES ES95941660T patent/ES2180664T3/es not_active Expired - Lifetime
- 1995-12-04 BR BR9510533A patent/BR9510533A/pt not_active IP Right Cessation
- 1995-12-04 EP EP95941660A patent/EP0799206B1/en not_active Expired - Lifetime
- 1995-12-04 RU RU97112144/04A patent/RU2163598C2/ru active
- 1995-12-06 TW TW084113009A patent/TW474920B/zh active
- 1995-12-15 MA MA24096A patent/MA23745A1/fr unknown
- 1995-12-15 IL IL11641095A patent/IL116410A/xx not_active IP Right Cessation
- 1995-12-18 MY MYPI95003929A patent/MY113214A/en unknown
-
1997
- 1997-06-18 FI FI972629A patent/FI116622B/fi not_active IP Right Cessation
- 1997-06-19 NO NO972841A patent/NO308297B1/no not_active IP Right Cessation
- 1997-06-19 MX MX9704588A patent/MX9704588A/es not_active IP Right Cessation
-
1999
- 1999-03-05 US US09/263,034 patent/US6133442A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI972629A0 (fi) | Aryyli- ja heteroaryylisulfonamidijohdoksia, niiden valmistus ja niiden käyttö endoteliinin antagonisteina | |
NO951813D0 (no) | Bicyklisk heterocyklisk sulfonamid og sulfonester-derivater | |
IL123585A0 (en) | Novel N-aminoalkylfluorene-carboxamides a new class of dopamine receptor subtype specific ligands | |
UA83243C2 (ru) | Соединения, которые ингибируют натриезависимый переносчик глюкозы | |
NO20052469L (no) | Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2. | |
TW350839B (en) | Sulfonamide derivative and process for preparing the same | |
NO20013369L (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
ES2159749T3 (es) | Derivados de bencilamino-2-metil-propanamidas 2-(4-sustituidas). | |
AU9281198A (en) | Benzofuran derivatives | |
EP1184373A4 (en) | TRICYCLIC CONNECTIONS | |
CA2120028A1 (en) | Indol Derivatives for the Treatment of Migrane | |
MX9704435A (es) | Compuestos de tiazolidinona y agente terapeutico o agente de prevencion para angina de pecho, que comprende los compuestos como un ingrediente activo. | |
DE69915471D1 (de) | Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
ATE48999T1 (de) | Piperazin-1-yl-ergolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
DK0782574T3 (da) | Bicycliske carboxiamider som 5-HT1A-receptorligander | |
ES2103675B1 (es) | Nuevas piperidinas sustituidas. | |
ATE119523T1 (de) | Isochinolinderivate und ihre salze als proteasehemmer. | |
EP1197211A4 (en) | CANCER PREVENTION AND TREATMENT ACTIVE INGREDIENTS | |
EP0782988A4 (en) | INDOL DERIVATIVES | |
ES2182775T3 (es) | Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion. | |
MX9706627A (es) | Derivado de tiazolidinona opticamente activo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 116622 Country of ref document: FI |
|
MA | Patent expired |